BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T, Mor G. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006;66:3859-3868. [PMID: 16585214 DOI: 10.1158/0008-5472.can-05-3948] [Cited by in Crossref: 338] [Cited by in F6Publishing: 194] [Article Influence: 21.1] [Reference Citation Analysis]
Number Citing Articles
1 Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions. ACS Infect Dis 2021;7:987-1009. [PMID: 33848139 DOI: 10.1021/acsinfecdis.0c00839] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
2 Zou Y, Qin F, Chen J, Meng J, Wei L, Wu C, Zhang Q, Wei D, Chen X, Wu H, Chen X, Dai S. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS. Oncotarget 2016;7:52032-44. [PMID: 27409669 DOI: 10.18632/oncotarget.10496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Park GS, Kim JH. Myeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cells. Oncotarget 2015;6:5749-59. [PMID: 25691060 DOI: 10.18632/oncotarget.3304] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yang J, Li M, Zheng QC. Emerging role of Toll-like receptor 4 in hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:11-7. [PMID: 27508190 DOI: 10.2147/JHC.S44515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
5 Semlali A, Reddy Parine N, Arafah M, Mansour L, Azzi A, Al Shahrani O, Al Amri A, Shaik JP, Aljebreen AM, Alharbi O, Almadi MA, Azzam NA, Kohailan M, Rouabhia M, Alanazi MS. Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients. PLoS One 2016;11:e0146333. [PMID: 26771524 DOI: 10.1371/journal.pone.0146333] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
6 Ehsan N, Murad S, Ashiq T, Mansoor MU, Gul S, Khalid S, Younas M. Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast. Tumour Biol 2013;34:1053-9. [PMID: 23338716 DOI: 10.1007/s13277-013-0645-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
7 Krockenberger M, Dombrowski Y, Weidler C, Ossadnik M, Hönig A, Häusler S, Voigt H, Becker JC, Leng L, Steinle A, Weller M, Bucala R, Dietl J, Wischhusen J. Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol 2008;180:7338-48. [PMID: 18490733 DOI: 10.4049/jimmunol.180.11.7338] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 7.4] [Reference Citation Analysis]
8 d'Adhemar CJ, Spillane CD, Gallagher MF, Bates M, Costello KM, Barry-O'Crowley J, Haley K, Kernan N, Murphy C, Smyth PC, O'Byrne K, Pennington S, Cooke AA, Ffrench B, Martin CM, O'Donnell D, Hennessy B, Stordal B, Finn S, McCann A, Gleeson N, D'Arcy T, Flood B, O'Neill LA, Sheils O, O'Toole S, O'Leary JJ. The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer. PLoS One 2014;9:e100816. [PMID: 24977712 DOI: 10.1371/journal.pone.0100816] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
9 Van Dessel N, Swofford CA, Forbes NS. Potent and tumor specific: arming bacteria with therapeutic proteins. Ther Deliv 2015;6:385-99. [PMID: 25853312 DOI: 10.4155/tde.14.113] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
10 Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 2021;221:107753. [PMID: 33259885 DOI: 10.1016/j.pharmthera.2020.107753] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Cheng H, Wang Z, Cui L, Wen Y, Chen X, Gong F, Yi H. Opportunities and Challenges of the Human Microbiome in Ovarian Cancer. Front Oncol 2020;10:163. [PMID: 32133297 DOI: 10.3389/fonc.2020.00163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
12 Park GB, Kim D. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells. Neoplasia 2019;21:206-15. [PMID: 30622051 DOI: 10.1016/j.neo.2018.12.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
13 Rezania S, Amirmozaffari N, Rashidi N, Mirzadegan E, Zarei S, Ghasemi J, Zarei O, Katouzian L, Zarnani AH. The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligation. Cancer Cell Int 2014;14:54. [PMID: 24966802 DOI: 10.1186/1475-2867-14-54] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ffrench B, Gasch C, O'Leary JJ, Gallagher MF. Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention. Mol Cancer 2014;13:262. [PMID: 25495823 DOI: 10.1186/1476-4598-13-262] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
15 Koyande N, Gangopadhyay M, Thatikonda S, Rengan AK. The role of gut microbiota in the development of colorectal cancer: a review. Int J Colorectal Dis 2022. [PMID: 35704091 DOI: 10.1007/s00384-022-04192-w] [Reference Citation Analysis]
16 Kim SI, Kang N, Leem S, Yang J, Jo H, Lee M, Kim HS, Dhanasekaran DN, Kim YK, Park T, Song YS. Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian Tumor. Cancers (Basel) 2020;12:E1309. [PMID: 32455705 DOI: 10.3390/cancers12051309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2:e845. [PMID: 17786216 DOI: 10.1371/journal.pone.0000845] [Cited by in Crossref: 482] [Cited by in F6Publishing: 468] [Article Influence: 32.1] [Reference Citation Analysis]
18 Ferreira GM, Martinez M, Camargo IC, Domeniconi RF, Martinez FE, Chuffa LG. Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats. J Cancer 2014;5:728-35. [PMID: 25368672 DOI: 10.7150/jca.10196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
19 Li D, Jia H, Zhang H, Lv M, Liu J, Zhang Y, Huang T, Huang B. TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b. Oncoimmunology 2012;1:687-93. [PMID: 22934260 DOI: 10.4161/onci.19854] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 28.0] [Reference Citation Analysis]
20 Pakala SB, Reddy SDN, Bui-Nguyen TM, Rangparia SS, Bommana A, Kumar R. MTA1 coregulator regulates LPS response via MyD88-dependent signaling. J Biol Chem 2010;285:32787-92. [PMID: 20702415 DOI: 10.1074/jbc.M110.151340] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
21 Jang GY, Lee JW, Kim YS, Lee SE, Han HD, Hong KJ, Kang TH, Park YM. Interactions between tumor-derived proteins and Toll-like receptors. Exp Mol Med 2020;52:1926-35. [PMID: 33299138 DOI: 10.1038/s12276-020-00540-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Nihon-Yanagi Y, Terai K, Murano T, Matsumoto T, Okazumi S. Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer. Cancer Immunol Immunother. 2012;61:71-77. [PMID: 21845432 DOI: 10.1007/s00262-011-1085-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
23 Goutagny N, Estornes Y, Hasan U, Lebecque S, Caux C. Targeting pattern recognition receptors in cancer immunotherapy. Target Oncol 2012;7:29-54. [PMID: 22399234 DOI: 10.1007/s11523-012-0213-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
24 Chen M, Wu J, Luo Q, Mo S, Lyu Y, Wei Y, Dong J. The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II. Nutrients 2016;8:E563. [PMID: 27649234 DOI: 10.3390/nu8090563] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
25 Huang JM, Zhang GN, Shi Y, Zha X, Zhu Y, Wang MM, Lin Q, Wang W, Lu HY, Ma SQ, Cheng J, Deng BF. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep 2014;4:3840. [PMID: 24452475 DOI: 10.1038/srep03840] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
26 Gamazon ER, Huang RS, Cox NJ. SCAN: a systems biology approach to pharmacogenomic discovery. Methods Mol Biol 2013;1015:213-24. [PMID: 23824859 DOI: 10.1007/978-1-62703-435-7_14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chang ZL. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res. 2010;59:791-808. [PMID: 20593217 DOI: 10.1007/s00011-010-0208-2] [Cited by in Crossref: 141] [Cited by in F6Publishing: 139] [Article Influence: 11.8] [Reference Citation Analysis]
28 Liang XY, Li Y, Ma YQ, Zhang ZM, He YL. Clinical significance of expression of high mobility group protein B1 and Toll-like receptor 4 in esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(23): 3495-3501 [DOI: 10.11569/wcjd.v24.i23.3495] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Linder M, Pogge von Strandmann E. The Role of Extracellular HSP70 in the Function of Tumor-Associated Immune Cells. Cancers (Basel) 2021;13:4721. [PMID: 34572948 DOI: 10.3390/cancers13184721] [Reference Citation Analysis]
30 Yang C, Yun Q, Sun H, Yang G, Liang T, Zhang C, Song J, Han J, Hou G. Non-invasive imaging of Toll-like receptor 5 expression using 131I-labeled mAb in the mice bearing H22 tumors. Oncol Lett 2014;7:1919-24. [PMID: 24932259 DOI: 10.3892/ol.2014.2025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Yang X, Cheng Y, Li C. The role of TLRs in cervical cancer with HPV infection: a review. Signal Transduct Target Ther 2017;2:17055. [PMID: 29263932 DOI: 10.1038/sigtrans.2017.55] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
32 Zhu J, Mohan C. Toll-like receptor signaling pathways--therapeutic opportunities. Mediators Inflamm 2010;2010:781235. [PMID: 20981241 DOI: 10.1155/2010/781235] [Cited by in Crossref: 83] [Cited by in F6Publishing: 104] [Article Influence: 6.9] [Reference Citation Analysis]
33 So EY, Ouchi T. The application of Toll like receptors for cancer therapy. Int J Biol Sci 2010;6:675-81. [PMID: 21060729 DOI: 10.7150/ijbs.6.675] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
34 Zhao B, Niu X, Huang S, Yang J, Wei Y, Wang X, Wang J, Wang Y, Guo X, Urzua U. TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-κB/HIF-1α Loop in Human Epithelial Ovarian Cancer. Analytical Cellular Pathology 2022;2022:1-19. [DOI: 10.1155/2022/4201262] [Reference Citation Analysis]
35 Mor G, Yin G, Chefetz I, Yang Y, Alvero A. Ovarian cancer stem cells and inflammation. Cancer Biol Ther 2011;11:708-13. [PMID: 21317559 DOI: 10.4161/cbt.11.8.14967] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
36 Jatoi A, Vierkant RA, Hawthorne KM, Block MS, Ramus SJ, Larson NB, Fridley BL, Goode EL. Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer. Oncology 2016;90:59-68. [PMID: 26780780 DOI: 10.1159/000442710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Shi L, Zheng X, Fan Y, Yang X, Li A, Qian J. The contribution of miR-122 to the innate immunity by regulating toll-like receptor 4 in hepatoma cells. BMC Gastroenterol 2019;19:130. [PMID: 31340754 DOI: 10.1186/s12876-019-1048-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
38 Harashima N, Minami T, Uemura H, Harada M. Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system. Mol Cancer 2014;13:217. [PMID: 25227113 DOI: 10.1186/1476-4598-13-217] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
39 Jiang Y, Wan Y, Gong M, Zhou S, Qiu J, Cheng W. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway. J Cell Mol Med 2020;24:6137-48. [PMID: 32329191 DOI: 10.1111/jcmm.15228] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
40 Ge H, Yan Y, Wu D, Huang Y, Tian F. Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics. Onco Targets Ther 2018;11:4845-55. [PMID: 30147336 DOI: 10.2147/OTT.S173225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
41 Bunt SK, Clements VK, Hanson EM, Sinha P, Ostrand-Rosenberg S. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J Leukoc Biol 2009;85:996-1004. [PMID: 19261929 DOI: 10.1189/jlb.0708446] [Cited by in Crossref: 174] [Cited by in F6Publishing: 162] [Article Influence: 13.4] [Reference Citation Analysis]
42 Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol. 2013;10:169-174. [PMID: 23296026 DOI: 10.4161/rna.23144] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 11.0] [Reference Citation Analysis]
43 Huang Y, Cai B, Xu M, Qiu Z, Tao Y, Zhang Y, Wang J, Xu Y, Zhou Y, Yang J, Han X, Gao Q. Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines. PLoS One. 2012;7:e38890. [PMID: 22815694 DOI: 10.1371/journal.pone.0038890] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
44 Madeira JM, Gibson DL, Kean WF, Klegeris A. The biological activity of auranofin: implications for novel treatment of diseases. Inflammopharmacology 2012;20:297-306. [PMID: 22965242 DOI: 10.1007/s10787-012-0149-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 10.6] [Reference Citation Analysis]
45 Hombach-Klonisch S, Natarajan S, Thanasupawat T, Medapati M, Pathak A, Ghavami S, Klonisch T. Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells. Front Endocrinol (Lausanne). 2014;5:37. [PMID: 24723911 DOI: 10.3389/fendo.2014.00037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
46 Alvero AB, Montagna MK, Chen R, Kim KH, Kyungjin K, Visintin I, Fu HH, Brown D, Mor G. NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. Cancer 2009;115:3204-16. [PMID: 19472400 DOI: 10.1002/cncr.24397] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
47 Chefetz I, Holmberg JC, Alvero AB, Visintin I, Mor G. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway. Cell Cycle 2011;10:2206-14. [PMID: 21623171 DOI: 10.4161/cc.10.13.16348] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
48 Sato Y, Goto Y, Narita N, Hoon DS. Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Cancer Microenviron. 2009;2 Suppl 1:205-214. [PMID: 19685283 DOI: 10.1007/s12307-009-0022-y] [Cited by in Crossref: 182] [Cited by in F6Publishing: 181] [Article Influence: 14.0] [Reference Citation Analysis]
49 Zhu Y, Huang JM, Zhang GN, Zha X, Deng BF. Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells. J Transl Med 2012;10:77. [PMID: 22533866 DOI: 10.1186/1479-5876-10-77] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
50 Bradbury M, Borràs E, Pérez-Benavente A, Gil-Moreno A, Santamaria A, Sabidó E. Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review. Cancers (Basel) 2021;13:2067. [PMID: 33922979 DOI: 10.3390/cancers13092067] [Reference Citation Analysis]
51 Lee SH, Hong B, Sharabi A, Huang XF, Chen SY. Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. Stem Cells. 2009;27:1604-1615. [PMID: 19544467 DOI: 10.1002/stem.75] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
52 Holtorf A, Conrad A, Holzmann B, Janssen KP. Cell-type specific MyD88 signaling is required for intestinal tumor initiation and progression to malignancy. Oncoimmunology 2018;7:e1466770. [PMID: 30221070 DOI: 10.1080/2162402X.2018.1466770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Yusuf N. Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings. Front Immunol 2014;5:224. [PMID: 24904578 DOI: 10.3389/fimmu.2014.00224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
54 Gökyildirim MY, Grandel U, Hattar K, Dahlem G, Schuetz E, Leinberger FH, Eberle F, Sibelius U, Grimminger F, Seeger W, Engenhart-Cabillic R, Dikomey E, Subtil FSB. Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines. Oncotarget 2018;9:28976-88. [PMID: 29989005 DOI: 10.18632/oncotarget.25665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
55 Qiu Y, Yang X, Wang L, Gao K, Jiang Z. L-Arginine Inhibited Inflammatory Response and Oxidative Stress Induced by Lipopolysaccharide via Arginase-1 Signaling in IPEC-J2 Cells. Int J Mol Sci 2019;20:E1800. [PMID: 30979040 DOI: 10.3390/ijms20071800] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
56 Xu F, Wang F, Yang T, Sheng Y, Zhong T, Chen Y. Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells. Cancer Cell Int 2014;14:142. [PMID: 25550688 DOI: 10.1186/s12935-014-0142-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
57 Tosun S, Fried S, Niggemann B, Zänker KS, Dittmar T. Hybrid Cells Derived from Human Breast Cancer Cells and Human Breast Epithelial Cells Exhibit Differential TLR4 and TLR9 Signaling. Int J Mol Sci 2016;17:E726. [PMID: 27187369 DOI: 10.3390/ijms17050726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
58 Zhan Y, Xiang F, Wu R, Xu J, Ni Z, Jiang J, Kang X. MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88. J Ovarian Res 2015;8:48. [PMID: 26223974 DOI: 10.1186/s13048-015-0178-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
59 Asano N, Imatani A, Watanabe T, Fushiya J, Kondo Y, Jin X, Ara N, Uno K, Iijima K, Koike T, Strober W, Shimosegawa T. Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses. Cancer Res. 2016;76:1135-1145. [PMID: 26759244 DOI: 10.1158/0008-5472.can-15-2272] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
60 Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC, Oidtman J, Silasi DA, Mor G. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells. 2009;27:2405-2413. [PMID: 19658191 DOI: 10.1002/stem.191] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 9.3] [Reference Citation Analysis]
61 Burn OK, Prasit KK, Hermans IF. Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists. Cancers (Basel) 2020;12:E3824. [PMID: 33352882 DOI: 10.3390/cancers12123824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Balistreri CR, Colonna-Romano G, Lio D, Candore G, Caruso C. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol 2009;29:406-15. [PMID: 19459036 DOI: 10.1007/s10875-009-9297-5] [Cited by in Crossref: 92] [Cited by in F6Publishing: 80] [Article Influence: 7.1] [Reference Citation Analysis]
63 Charbonneau B, Goode EL, Kalli KR, Knutson KL, Derycke MS. The immune system in the pathogenesis of ovarian cancer. Crit Rev Immunol 2013;33:137-64. [PMID: 23582060 DOI: 10.1615/critrevimmunol.2013006813] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
64 Othman N, Jamal R, Abu N. Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players. Front Immunol 2019;10:2103. [PMID: 31555295 DOI: 10.3389/fimmu.2019.02103] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
65 Matijevic T, Pavelic J. The dual role of TLR3 in metastatic cell line. Clin Exp Metastasis 2011;28:701-12. [PMID: 21735101 DOI: 10.1007/s10585-011-9402-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
66 Hajam IA, Dar PA, Shahnawaz I, Jaume JC, Lee JH. Bacterial flagellin-a potent immunomodulatory agent. Exp Mol Med 2017;49:e373. [PMID: 28860663 DOI: 10.1038/emm.2017.172] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 17.4] [Reference Citation Analysis]
67 Ren T, Xu L, Jiao S, Wang Y, Cai Y, Liang Y, Zhou Y, Zhou H, Wen Z. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res 2009;15:623-30. [PMID: 19319670 DOI: 10.1007/s12253-009-9162-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
68 Chefetz I, Alvero AB, Holmberg JC, Lebowitz N, Craveiro V, Yang-Hartwich Y, Yin G, Squillace L, Gurrea Soteras M, Aldo P, Mor G. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence. Cell Cycle 2013;12:511-21. [PMID: 23324344 DOI: 10.4161/cc.23406] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
69 Park HD, Lee Y, Oh YK, Jung JG, Park YW, Myung K, Kim KH, Koh SS, Lim DS. Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. Oncogene 2011;30:201-11. [PMID: 20802527 DOI: 10.1038/onc.2010.401] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
70 Cherfils-Vicini J, Platonova S, Gillard M, Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F, Dieu-Nosjean MC, Fridman WH. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest. 2010;120:1285-1297. [PMID: 20237413 DOI: 10.1172/jci36551] [Cited by in Crossref: 144] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
71 Mleko M, Pitynski K, Pluta E, Czerw A, Sygit K, Karakiewicz B, Banas T. Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies - State of the Art. Cancer Manag Res 2021;13:5491-508. [PMID: 34276227 DOI: 10.2147/CMAR.S312828] [Reference Citation Analysis]
72 Porru M, Zizza P, Panera N, Alisi A, Biroccio A, Leonetti C. Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1830. [PMID: 32650388 DOI: 10.3390/cancers12071830] [Reference Citation Analysis]
73 Makhijani P, Mcgaha TL. Myeloid Responses to Extracellular Vesicles in Health and Disease. Front Immunol 2022;13:818538. [DOI: 10.3389/fimmu.2022.818538] [Reference Citation Analysis]
74 Le Noci V, Bernardo G, Bianchi F, Tagliabue E, Sommariva M, Sfondrini L. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression. Front Cell Dev Biol 2021;9:732192. [PMID: 34604233 DOI: 10.3389/fcell.2021.732192] [Reference Citation Analysis]
75 Trucco LD, Roselli E, Araya P, Nuñez NG, Mena HA, Bocco JL, Negrotto S, Maccioni M. Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma. PLoS One 2017;12:e0179897. [PMID: 28662055 DOI: 10.1371/journal.pone.0179897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
76 Lam-ubol A, Hopkin D, Letuchy EM, Kurago ZB. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes. Inflammation 2010;33:207-23. [PMID: 20084448 DOI: 10.1007/s10753-009-9175-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
77 Chun KS, Kim DH, Raut PK, Surh YJ. Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 2021:S1044-579X(21)00279-0. [PMID: 34838956 DOI: 10.1016/j.semcancer.2021.11.006] [Reference Citation Analysis]
78 Bates M, Spillane CD, Gallagher MF, McCann A, Martin C, Blackshields G, Keegan H, Gubbins L, Brooks R, Brooks D, Selemidis S, O'Toole S, O'Leary JJ. The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer. PLoS One 2020;15:e0243715. [PMID: 33370338 DOI: 10.1371/journal.pone.0243715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Wang Y, Weng Y, Shi Y, Xia X, Wang S, Duan H. Expression and functional analysis of Toll-like receptor 4 in human cervical carcinoma. J Membr Biol 2014;247:591-9. [PMID: 24878539 DOI: 10.1007/s00232-014-9675-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
80 Lanki M, Seppänen H, Mustonen H, Hagström J, Haglund C. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer. PLoS One 2019;14:e0219245. [PMID: 31314777 DOI: 10.1371/journal.pone.0219245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
81 Matzner P, Sandbank E, Neeman E, Zmora O, Gottumukkala V, Ben-Eliyahu S. Harnessing cancer immunotherapy during the unexploited immediate perioperative period. Nat Rev Clin Oncol 2020;17:313-26. [PMID: 32066936 DOI: 10.1038/s41571-019-0319-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
82 Yang-Hartwich Y, Tedja R, Roberts CM, Goodner-Bingham J, Cardenas C, Gurea M, Sumi NJ, Alvero AB, Glackin CA, Mor G. p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT. Mol Cancer Res 2019;17:153-64. [PMID: 30131448 DOI: 10.1158/1541-7786.MCR-18-0238] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
83 Bhattacharya D, Yusuf N. Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment. Int J Breast Cancer 2012;2012:716564. [PMID: 22295250 DOI: 10.1155/2012/716564] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
84 Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res. 2010;29:92. [PMID: 20618976 DOI: 10.1186/1756-9966-29-92] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 9.1] [Reference Citation Analysis]
85 Sun H, Hu P, Du J, Wang X. Predictive value of inflammatory indexes on the chemotherapeutic response in patients with unresectable lung cancer: A retrospective study. Oncol Lett 2018;15:4017-25. [PMID: 29467910 DOI: 10.3892/ol.2018.7781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
86 Liu X, Liang J, Li G. Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15. Mol Biol Rep. 2010;37:2235-2239. [PMID: 19680784 DOI: 10.1007/s11033-009-9710-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
87 Shukoor MI, Natalio F, Tahir MN, Wiens M, Tarantola M, Therese HA, Barz M, Weber S, Terekhov M, Schrã¶der HC, Mã¼ller WEG, Janshoff A, Theato P, Zentel R, Schreiber LM, Tremel W. Pathogen-Mimicking MnO Nanoparticles for Selective Activation of the TLR9 Pathway and Imaging of Cancer Cells. Adv Funct Mater 2009;19:3717-25. [DOI: 10.1002/adfm.200900635] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
88 Petricevic B, Vrbanec D, Jakic-Razumovic J, Brcic I, Rabic D, Badovinac T, Ozimec E, Bali V. Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer. Med Oncol 2012;29:486-94. [PMID: 21400218 DOI: 10.1007/s12032-011-9885-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
89 Saito T, Sasaki CY, Rezanka LJ, Ghosh P, Longo DL. p52-Independent nuclear translocation of RelB promotes LPS-induced attachment. Biochem Biophys Res Commun 2010;391:235-41. [PMID: 19903458 DOI: 10.1016/j.bbrc.2009.11.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
90 Tewari R, Choudhury SR, Ghosh S, Mehta VS, Sen E. Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma. J Mol Med (Berl) 2012;90:67-80. [PMID: 21887505 DOI: 10.1007/s00109-011-0807-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
91 Cort A, Ozben T, Saso L, De Luca C, Korkina L. Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants. Oxid Med Cell Longev 2016;2016:4251912. [PMID: 26881027 DOI: 10.1155/2016/4251912] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
92 Zhou W, Chen X, Hu Q, Chen X, Chen Y, Huang L. Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression. BMC Cancer 2018;18:580. [PMID: 29788922 DOI: 10.1186/s12885-018-4461-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
93 Park GB, Kim D. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production. Mol Cell Biochem 2017;425:191-202. [PMID: 27837433 DOI: 10.1007/s11010-016-2873-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
94 Zeromski J, Mozer-Lisewska I, Kaczmarek M. Significance of toll-like receptors expression in tumor growth and spreading: a short review. Cancer Microenviron 2008;1:37-42. [PMID: 19308683 DOI: 10.1007/s12307-008-0005-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
95 Liu J, Xu D, Wang Q, Zheng D, Jiang X, Xu L. LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4. Dig Dis Sci 2014;59:1452-60. [PMID: 24532253 DOI: 10.1007/s10620-014-3049-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
96 Afzal A, Sarfraz M, Li GL, Ji SP, Duan SF, Khan NH, Wu DD, Ji XY. Taking a holistic view of PEST-containing nuclear protein (PCNP) in cancer biology. Cancer Med 2019;8:6335-43. [PMID: 31487123 DOI: 10.1002/cam4.2465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
97 Zhang QQ, Ding Y, Lei Y, Qi CL, He XD, Lan T, Li JC, Gong P, Yang X, Geng JG, Wang LJ. Andrographolide suppress tumor growth by inhibiting TLR4/NF-κB signaling activation in insulinoma. Int J Biol Sci 2014;10:404-14. [PMID: 24719558 DOI: 10.7150/ijbs.7723] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
98 Alvero AB. Recent insights into the role of NF-kappaB in ovarian carcinogenesis. Genome Med 2010;2:56. [PMID: 20804565 DOI: 10.1186/gm177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
99 Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle. 2009;8:158-166. [PMID: 19158483 DOI: 10.4161/cc.8.1.7533] [Cited by in Crossref: 338] [Cited by in F6Publishing: 314] [Article Influence: 26.0] [Reference Citation Analysis]
100 Bondhopadhyay B, Moirangthem A, Basu A. Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface. Tumour Biol 2015;36:1261-71. [PMID: 25348355 DOI: 10.1007/s13277-014-2737-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
101 Eiró N, Vizoso FJ. Inflammation and cancer. World J Gastrointest Surg 2012; 4(3): 62-72 [PMID: 22530080 DOI: 10.4240/wjgs.v4.i3.62] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 80] [Article Influence: 8.6] [Reference Citation Analysis]
102 Zheng S, Fu W, Ma R, Huang Q, Gu J, Zhou J, Lu K, Guo G. Suppression of MD2 inhibits breast cancer in vitro and in vivo. Clin Transl Oncol 2021;23:1811-7. [PMID: 33733435 DOI: 10.1007/s12094-021-02587-9] [Reference Citation Analysis]
103 Morale MG, Tamura RE, Cintra R, Araújo NM, Villa LL. TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09980-6] [Reference Citation Analysis]
104 Scheenstra MR, van Harten RM, Veldhuizen EJA, Haagsman HP, Coorens M. Cathelicidins Modulate TLR-Activation and Inflammation. Front Immunol 2020;11:1137. [PMID: 32582207 DOI: 10.3389/fimmu.2020.01137] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
105 Jiang J, Dong L, Qin B, Shi H, Guo X, Wang Y. Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells. Oncol Lett 2016;12:631-6. [PMID: 27347192 DOI: 10.3892/ol.2016.4617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
106 Kim TH, Suh DH, Kim MK, Song YS. Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer. Biomed Res Int 2014;2014:132702. [PMID: 25050322 DOI: 10.1155/2014/132702] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
107 Laderach DJ, Compagno D. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure. Cancers (Basel) 2021;13:4529. [PMID: 34572756 DOI: 10.3390/cancers13184529] [Reference Citation Analysis]
108 Fried S, Tosun S, Troost G, Keil S, Zaenker KS, Dittmar T. Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial × Breast Cancer Hybrids, but Not in Parental Cells. PLoS One 2016;11:e0148438. [PMID: 26863029 DOI: 10.1371/journal.pone.0148438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
109 Muehleisen B, Jiang SB, Gladsjo JA, Gerber M, Hata T, Gallo RL. Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients. PLoS One 2012;7:e40754. [PMID: 22808251 DOI: 10.1371/journal.pone.0040754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
110 Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Abdullah Ajaj S, Rouabhia M, Alanazi MS. Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women. Onco Targets Ther 2017;10:1207-16. [PMID: 28280355 DOI: 10.2147/OTT.S112165] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
111 Wang AC, Ma YB, Wu FX, Ma ZF, Liu NF, Gao R, Gao YS, Sheng XG. TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro.. Oncol Lett 2014;7:871-7. [PMID: 24527095 DOI: 10.3892/ol.2013.1759] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
112 Di JM, Pang J, Sun QP, Zhang Y, Fang YQ, Liu XP, Zhou JH, Ruan XX, Gao X. Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells. Mol Biol Rep 2010;37:1849-55. [PMID: 19618291 DOI: 10.1007/s11033-009-9620-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
113 Oblak A, Jerala R. Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol 2011;2011:609579. [PMID: 22110526 DOI: 10.1155/2011/609579] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
114 Boutajangout A, Wisniewski T. The innate immune system in Alzheimer's disease. Int J Cell Biol 2013;2013:576383. [PMID: 24223593 DOI: 10.1155/2013/576383] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
115 Dajon M, Iribarren K, Cremer I. Dual roles of TLR7 in the lung cancer microenvironment. Oncoimmunology 2015;4:e991615. [PMID: 25949912 DOI: 10.4161/2162402X.2014.991615] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
116 Xu C, Li H, Yin M, Yang T, An L, Yang G. Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis. Oncotarget 2017;8:98394-404. [PMID: 29228698 DOI: 10.18632/oncotarget.21844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
117 Khare VM, Saxena VK, Pasternak MA, Nyinawabera A, Singh KB, Ashby CR Jr, Tiwari AK, Tang Y. The expression profiles of chemokines, innate immune and apoptotic genes in tumors caused by Rous Sarcoma Virus (RSV-A) in chickens. Genes Immun 2021. [PMID: 34934184 DOI: 10.1038/s41435-021-00158-0] [Reference Citation Analysis]
118 Rakhesh M, Cate M, Vijay R, Shrikant A, Shanjana A. A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells. Oncoimmunology 2012;1:1495-506. [PMID: 23264896 DOI: 10.4161/onci.22089] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 29.0] [Reference Citation Analysis]
119 Kim KH, Jo MS, Suh DS, Yoon MS, Shin DH, Lee JH, Choi KU. Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers. World J Surg Oncol 2012;10:193. [PMID: 22985132 DOI: 10.1186/1477-7819-10-193] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
120 Bangi E. Drosophila at the intersection of infection, inflammation, and cancer. Front Cell Infect Microbiol 2013;3:103. [PMID: 24392358 DOI: 10.3389/fcimb.2013.00103] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
121 Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010;14:2592-2603. [PMID: 20629986 DOI: 10.1111/j.1582-4934.2010.01127.x] [Cited by in Crossref: 313] [Cited by in F6Publishing: 301] [Article Influence: 28.5] [Reference Citation Analysis]
122 Wang J, Lin D, Peng H, Shao J, Gu J. Cancer-derived immunoglobulin G promotes LPS-induced proinflammatory cytokine production via binding to TLR4 in cervical cancer cells. Oncotarget 2014;5:9727-43. [PMID: 25179302 DOI: 10.18632/oncotarget.2359] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
123 Huang J, Xu Y, Xiao H, Xiao Z, Guo Y, Cheng D, Shuai X. Core-Shell Distinct Nanodrug Showing On-Demand Sequential Drug Release To Act on Multiple Cell Types for Synergistic Anticancer Therapy. ACS Nano 2019;13:7036-49. [PMID: 31141661 DOI: 10.1021/acsnano.9b02149] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
124 Szajnik M, Szczepanski MJ, Czystowska M, Elishaev E, Mandapathil M, Nowak-Markwitz E, Spaczynski M, Whiteside TL. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene 2009;28:4353-63. [PMID: 19826413 DOI: 10.1038/onc.2009.289] [Cited by in Crossref: 148] [Cited by in F6Publishing: 146] [Article Influence: 12.3] [Reference Citation Analysis]
125 Lupi LA, Delella FK, Cucielo MS, Romagnoli GG, Kaneno R, Nunes IDS, Domeniconi RF, Martinez M, Martinez FE, Fávaro WJ, Chuffa LGA. P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study. Molecules 2019;25:E5. [PMID: 31861351 DOI: 10.3390/molecules25010005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
126 Ilinskaya AN, Clogston JD, McNeil SE, Dobrovolskaia MA. Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA. Nanomedicine 2015;11:1925-38. [PMID: 26282378 DOI: 10.1016/j.nano.2015.07.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
127 de Almeida Chuffa LG, de Moura Ferreira G, Lupi LA, da Silva Nunes I, Fávaro WJ. P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling. J Ovarian Res 2018;11:8. [PMID: 29343281 DOI: 10.1186/s13048-018-0380-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
128 Zheng W, Wang Q, Lu X, Shi Q, Zou J, Tao Y, Wang P. Protective Effects of Dracocephalum heterophyllum in ConA-Induced Acute Hepatitis. Mediators Inflamm 2016;2016:2684321. [PMID: 27524863 DOI: 10.1155/2016/2684321] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
129 Woods DC, White YA, Dau C, Johnson AL. TLR4 activates NF-κB in human ovarian granulosa tumor cells. Biochem Biophys Res Commun. 2011;409:675-680. [PMID: 21616060 DOI: 10.1016/j.bbrc.2011.05.063] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
130 Yuan X, Zhou Y, Wang W, Li J, Xie G, Zhao Y, Xu D, Shen L. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production. Cell Death Dis. 2013;4:e794. [PMID: 24030146 DOI: 10.1038/cddis.2013.334] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
131 Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, Oszurek O, Orsulic S, Ness RB, Nelson G, Modugno F, Menkiszak J, McGuire V, McCauley BM, Mack M, Lubiński J, Longacre TA, Li Z, Lester J, Kennedy CJ, Kalli KR, Jung AY, Johnatty SE, Jimenez-Linan M, Jensen A, Intermaggio MP, Hung J, Herpel E, Hernandez BY, Hartkopf AD, Harnett PR, Ghatage P, García-Bueno JM, Gao B, Fereday S, Eilber U, Edwards RP, de Sousa CB, de Andrade JM, Chudecka-Głaz A, Chenevix-Trench G, Cazorla A, Brucker SY, Alsop J, Whittemore AS, Steed H, Staebler A, Moysich KB, Menon U, Koziak JM, Kommoss S, Kjaer SK, Kelemen LE, Karlan BY, Huntsman DG, Høgdall E, Gronwald J, Goodman MT, Gilks B, García MJ, Fasching PA, de Fazio A, Deen S, Chang-Claude J, Candido Dos Reis FJ, Campbell IG, Brenton JD, Bowtell DD, Benítez J, Pharoah PDP, Köbel M, Ramus SJ, Goode EL; Australian Ovarian Cancer Study Group. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 2018;93:307-20. [PMID: 29502561 DOI: 10.1016/j.mayocp.2017.10.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
132 Uppal T, Sarkar R, Dhelaria R, Verma SC. Role of Pattern Recognition Receptors in KSHV Infection. Cancers (Basel) 2018;10:E85. [PMID: 29558453 DOI: 10.3390/cancers10030085] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
133 Berquin IM, Edwards IJ, Kridel SJ, Chen YQ. Polyunsaturated fatty acid metabolism in prostate cancer. Cancer Metastasis Rev 2011;30:295-309. [PMID: 22015690 DOI: 10.1007/s10555-011-9299-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
134 Nguyen AH, Elliott IA, Wu N, Matsumura C, Vogelauer M, Attar N, Dann A, Ghukasyan R, Toste PA, Patel SG, Williams JL, Li L, Dawson DW, Radu C, Kurdistani SK, Donahue TR. Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. Oncotarget 2017;8:19074-88. [PMID: 27894105 DOI: 10.18632/oncotarget.13572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
135 Hao B, Chen Z, Bi B, Yu M, Yao S, Feng Y, Yu Y, Pan L, Di D, Luo G, Zhang X. Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis. Oncotarget 2018;9:13088-99. [PMID: 29560134 DOI: 10.18632/oncotarget.24178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
136 Ma FJ, Liu ZB, Hu X, Ling H, Li S, Wu J, Shao ZM. Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients. PLoS One 2014;9:e111639. [PMID: 25360699 DOI: 10.1371/journal.pone.0111639] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
137 Kim KH, Xie Y, Tytler EM, Woessner R, Mor G, Alvero AB. KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells. J Transl Med 2009;7:63. [PMID: 19619321 DOI: 10.1186/1479-5876-7-63] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
138 Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603-1616. [PMID: 20840865 DOI: 10.1016/j.freeradbiomed.2010.09.006] [Cited by in Crossref: 2540] [Cited by in F6Publishing: 2298] [Article Influence: 211.7] [Reference Citation Analysis]
139 Kim HJ, Yim GW, Nam EJ, Kim YT. Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. Cancer Res Treat 2014;46:81-92. [PMID: 24520227 DOI: 10.4143/crt.2014.46.1.81] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
140 Edwardson DW, Boudreau J, Mapletoft J, Lanner C, Kovala AT, Parissenti AM. Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance. PLoS One 2017;12:e0183662. [PMID: 28915246 DOI: 10.1371/journal.pone.0183662] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
141 Okuyama H, Tominaga A, Fukuoka S, Taguchi T, Kusumoto Y, Ono S. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ. Oncol Rep 2017;37:684-94. [PMID: 28075473 DOI: 10.3892/or.2017.5346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
142 Zhang X, Liu Q, Liao Q, Zhao Y. Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy. J Cancer. 2020;11:2749-2758. [PMID: 32226493 DOI: 10.7150/jca.37445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
143 Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D. Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 2011;71:2466-75. [PMID: 21427357 DOI: 10.1158/0008-5472.CAN-10-1993] [Cited by in Crossref: 128] [Cited by in F6Publishing: 73] [Article Influence: 11.6] [Reference Citation Analysis]
144 González-Reyes S, Marín L, González L, González LO, del Casar JM, Lamelas ML, González-Quintana JM, Vizoso FJ. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer. 2010;10:665. [PMID: 21129170 DOI: 10.1186/1471-2407-10-665] [Cited by in Crossref: 131] [Cited by in F6Publishing: 136] [Article Influence: 10.9] [Reference Citation Analysis]
145 Zheng W, Du S, Tian M, Xu W, Tian Y, Li T, Fu Y, Wu S, Li C, Jin N. Lepidium meyenii Walp Exhibits Anti-Inflammatory Activity against ConA-Induced Acute Hepatitis. Mediators Inflamm 2018;2018:8982756. [PMID: 30647537 DOI: 10.1155/2018/8982756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
146 Di Vito Nolfi M, Vecchiotti D, Flati I, Verzella D, Di Padova M, Alesse E, Capece D, Zazzeroni F. EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player? Front Oncol 2022;12:933922. [DOI: 10.3389/fonc.2022.933922] [Reference Citation Analysis]
147 Kandalaft LE, Singh N, Liao JB, Facciabene A, Berek JS, Powell DJ Jr, Coukos G. The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade. Gynecol Oncol 2010;116:222-33. [PMID: 19959212 DOI: 10.1016/j.ygyno.2009.11.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
148 Tenenbaum JD, Walker MG, Utz PJ, Butte AJ. Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease. BMC Med Genomics 2008;1:51. [PMID: 18937865 DOI: 10.1186/1755-8794-1-51] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
149 Cai J, Li T, Huang B, Cheng H, Ding H, Dong W, Xiao M, Liu L, Wang Z. The use of laser microdissection in the identification of suitable reference genes for normalization of quantitative real-time PCR in human FFPE epithelial ovarian tissue samples. PLoS One 2014;9:e95974. [PMID: 24776823 DOI: 10.1371/journal.pone.0095974] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
150 Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC. Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer 2010;116:3276-84. [PMID: 20564628 DOI: 10.1002/cncr.25190] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
151 Lu SY, Hua J, Xu J, Wei MY, Liang C, Meng QC, Liu J, Zhang B, Wang W, Yu XJ, Shi S. Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions. Int J Biol Sci 2021;17:2666-82. [PMID: 34326701 DOI: 10.7150/ijbs.59117] [Reference Citation Analysis]
152 Ioannou S, Voulgarelis M. Toll-like receptors, tissue injury, and tumourigenesis. Mediators Inflamm 2010;2010:581837. [PMID: 20871832 DOI: 10.1155/2010/581837] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
153 Giurini EF, Madonna MB, Zloza A, Gupta KH. Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression. Cancers (Basel) 2022;14:2923. [PMID: 35740589 DOI: 10.3390/cancers14122923] [Reference Citation Analysis]
154 Steffensen KD, Alvero AB, Yang Y, Waldstrøm M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G. Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol 2011;2011:620523. [PMID: 21904548 DOI: 10.1155/2011/620523] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
155 Serda RE. Particle platforms for cancer immunotherapy. Int J Nanomedicine 2013;8:1683-96. [PMID: 23761969 DOI: 10.2147/IJN.S31756] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
156 Shaath H, Toor SM, Nair VS, Elkord E, Alajez NM. Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients. Cancers (Basel) 2019;11:E1994. [PMID: 31835892 DOI: 10.3390/cancers11121994] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
157 Singha B, Gatla HR, Vancurova I. Transcriptional regulation of chemokine expression in ovarian cancer. Biomolecules 2015;5:223-43. [PMID: 25790431 DOI: 10.3390/biom5010223] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
158 Wu HQ, Wang B, Zhu SK, Tian Y, Zhang JH, Wu HS. Effects of CPG ODN on biological behavior of PANC-1 and expression of TLR9 in pancreatic cancer. World J Gastroenterol 2011; 17(8): 996-1003 [PMID: 21448350 DOI: 10.3748/wjg.v17.i8.996] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
159 Ho TY, Mealiea D, Okamoto L, Stojdl DF, McCart JA. Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development. Mol Ther Oncolytics 2021;22:85-97. [PMID: 34514091 DOI: 10.1016/j.omto.2021.05.007] [Reference Citation Analysis]
160 Kumar N, Vyas A, Agnihotri SK, Chattopadhyay N, Sachdev M. Small secretory proteins of immune cells can modulate gynecological cancers. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.008] [Reference Citation Analysis]
161 Bourguignon LY, Wong G, Earle CA, Xia W. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken) 2011;68:671-93. [PMID: 22031535 DOI: 10.1002/cm.20544] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 5.9] [Reference Citation Analysis]
162 Zhang YL, Luan B, Wang XF, Qiao JY, Song L, Lei RR, Gao WX, Liu Y. Peripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development. PLoS One 2013;8:e63775. [PMID: 23717481 DOI: 10.1371/journal.pone.0063775] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
163 Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF, Hoon DS. Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther 2008;7:3642-53. [PMID: 19001446 DOI: 10.1158/1535-7163.MCT-08-0582] [Cited by in Crossref: 79] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
164 Sangwan V, Al-Marzouki L, Pal S, Stavrakos V, Alzahrani M, Antonatos D, Nevo Y, Camilleri-Broët S, Rayes R, Bourdeau F, Giannias B, Bertos N, Bailey S, Rousseau S, Cools-Lartigue J, Spicer JD, Ferri L. Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis. Clin Exp Metastasis 2021. [PMID: 34767138 DOI: 10.1007/s10585-021-10133-8] [Reference Citation Analysis]
165 Rajput S, Volk-Draper LD, Ran S. TLR4 is a novel determinant of the response to paclitaxel in breast cancer. Mol Cancer Ther. 2013;12:1676-1687. [PMID: 23720768 DOI: 10.1158/1535-7163.mct-12-1019] [Cited by in Crossref: 79] [Cited by in F6Publishing: 48] [Article Influence: 8.8] [Reference Citation Analysis]
166 Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(32): 3745-3751 [PMID: 21990957 DOI: 10.3748/wjg.v17.i32.3745] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
167 Muccioli M, Benencia F. Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies. Front Immunol 2014;5:341. [PMID: 25101083 DOI: 10.3389/fimmu.2014.00341] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
168 Sipos A, Ujlaki G, Mikó E, Maka E, Szabó J, Uray K, Krasznai Z, Bai P. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med 2021;27:33. [PMID: 33794773 DOI: 10.1186/s10020-021-00295-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
169 Sootichote R, Thuwajit P, Singsuksawat E, Warnnissorn M, Yenchitsomanus PT, Ithimakin S, Chantharasamee J, Thuwajit C. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8. BMC Cancer 2018;18:231. [PMID: 29486738 DOI: 10.1186/s12885-018-4155-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
170 Słotwiński R, Słotwińska SM. Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer. Cent Eur J Immunol 2016;41:404-18. [PMID: 28450804 DOI: 10.5114/ceji.2016.65140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
171 Zimmer SM, Liu J, Clayton JL, Stephens DS, Snyder JP. Paclitaxel binding to human and murine MD-2. J Biol Chem 2008;283:27916-26. [PMID: 18650420 DOI: 10.1074/jbc.M802826200] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
172 Li Z, Block MS, Vierkant RA, Fogarty ZC, Winham SJ, Visscher DW, Kalli KR, Wang C, Goode EL. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins. Tumour Biol 2016;37:13279-86. [PMID: 27460076 DOI: 10.1007/s13277-016-5163-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
173 Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer. 2010;102:908-915. [PMID: 20145615 DOI: 10.1038/sj.bjc.6605558] [Cited by in Crossref: 151] [Cited by in F6Publishing: 151] [Article Influence: 12.6] [Reference Citation Analysis]
174 Jones SK, Lizzio V, Merkel OM. Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance. Biomacromolecules 2016;17:76-87. [PMID: 26636884 DOI: 10.1021/acs.biomac.5b01189] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
175 Ren WH, Zhang LM, Liu HQ, Gao L, Chen C, Qiang C, Wang XL, Liu CY, Li SM, Huang C, Qi H, Zhi KQ. Protein overexpression of CIRP and TLR4 in oral squamous cell carcinoma: an immunohistochemical and clinical correlation analysis. Med Oncol 2014;31:120. [PMID: 25027624 DOI: 10.1007/s12032-014-0120-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
176 Zhan Z, Xie X, Cao H, Zhou X, Zhang XD, Fan H, Liu Z. Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy 2014;10:257-68. [PMID: 24321786 DOI: 10.4161/auto.27162] [Cited by in Crossref: 109] [Cited by in F6Publishing: 116] [Article Influence: 12.1] [Reference Citation Analysis]
177 Fekonja O, Avbelj M, Jerala R. Suppression of TLR signaling by targeting TIR domain-containing proteins. Curr Protein Pept Sci 2012;13:776-88. [PMID: 23305364 DOI: 10.2174/138920312804871148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
178 Hattar K, Savai R, Subtil FS, Wilhelm J, Schmall A, Lang DS, Goldmann T, Eul B, Dahlem G, Fink L, Schermuly RT, Banat GA, Sibelius U, Grimminger F, Vollmer E, Seeger W, Grandel U. Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation. Cancer Immunol Immunother 2013;62:309-20. [PMID: 22923191 DOI: 10.1007/s00262-012-1341-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
179 Ahmed A, Redmond HP, Wang JH. Links between Toll-like receptor 4 and breast cancer. Oncoimmunology 2013;2:e22945. [PMID: 23526132 DOI: 10.4161/onci.22945] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
180 Pandey S, Singh S, Anang V, Bhatt AN, Natarajan K, Dwarakanath BS. Pattern Recognition Receptors in Cancer Progression and Metastasis. Cancer Growth Metastasis 2015;8:25-34. [PMID: 26279628 DOI: 10.4137/CGM.S24314] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
181 Mempin M, Hu H, Vickery K, Kadin ME, Prince HM, Kouttab N, Morgan JW, Adams WP Jr, Deva AK. Gram-Negative Bacterial Lipopolysaccharide Promotes Tumor Cell Proliferation in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Cancers (Basel) 2021;13:5298. [PMID: 34771464 DOI: 10.3390/cancers13215298] [Reference Citation Analysis]
182 Li J, Alvero AB, Nuti S, Tedja R, Roberts CM, Pitruzzello M, Li Y, Xiao Q, Zhang S, Gan Y, Wu X, Mor G, Yin G. CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential. Oncogene 2020;39:3965-79. [PMID: 32205869 DOI: 10.1038/s41388-020-1269-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
183 Paone A, Galli R, Gabellini C, Lukashev D, Starace D, Gorlach A, De Cesaris P, Ziparo E, Del Bufalo D, Sitkovsky MV, Filippini A, Riccioli A. Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. Neoplasia 2010;12:539-49. [PMID: 20651983 DOI: 10.1593/neo.92106] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
184 Fávaro WJ, Nunes OS, Seiva FR, Nunes IS, Woolhiser LK, Durán N, Lenaerts AJ. Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer. Infect Agent Cancer 2012;7:14. [PMID: 22709446 DOI: 10.1186/1750-9378-7-14] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
185 Alvero AB, Montagna MK, Craveiro V, Liu L, Mor G. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype. Am J Reprod Immunol 2012;67:256-65. [PMID: 21917055 DOI: 10.1111/j.1600-0897.2011.01068.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
186 Ou T, Lilly M, Jiang W. The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer. Front Immunol 2018;9:1188. [PMID: 29928275 DOI: 10.3389/fimmu.2018.01188] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
187 Mai CW, Kang YB, Pichika MR. Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther 2013;6:1573-87. [PMID: 24235843 DOI: 10.2147/OTT.S50838] [Cited by in Crossref: 19] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
188 Jia RJ, Cao L, Zhang L, Jing W, Chen R, Zhu MH, Guo SW, Wu GB, Fan XY, Wang H, Zhang YY, Zhou XY, Zhao J, Guo YJ. Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma. Cell Death Dis 2014;5:e1103. [PMID: 24603331 DOI: 10.1038/cddis.2014.71] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
189 Chuffa LG, Fioruci-Fontanelli BA, Mendes LO, Ferreira Seiva FR, Martinez M, Fávaro WJ, Domeniconi RF, Pinheiro PF, Delazari Dos Santos L, Martinez FE. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer. BMC Cancer. 2015;15:34. [PMID: 25655081 DOI: 10.1186/s12885-015-1032-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
190 Choi CH, Kang TH, Song JS, Kim YS, Chung EJ, Ylaya K, Kim S, Koh SS, Chung JY, Kim JH, Hewitt SM. Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer. Sci Rep 2018;8:12161. [PMID: 30111860 DOI: 10.1038/s41598-018-30582-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
191 Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene. 2008;27:4712-4723. [PMID: 18408758 DOI: 10.1038/onc.2008.112] [Cited by in Crossref: 213] [Cited by in F6Publishing: 220] [Article Influence: 15.2] [Reference Citation Analysis]
192 Kim KH, Park SH, Do KH, Kim J, Choi KU, Moon Y. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Oncotarget 2016;7:72148-66. [PMID: 27708225 DOI: 10.18632/oncotarget.12355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
193 Pandey N, Chauhan A, Jain N. TLR4 Polymorphisms and Expression in Solid Cancers. Mol Diagn Ther 2018;22:683-702. [PMID: 30311146 DOI: 10.1007/s40291-018-0361-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
194 Yu S, Cho HH, Joo HJ, Bae YC, Jung JS. Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells. Mol Cell Biochem 2008;317:143-50. [PMID: 18581201 DOI: 10.1007/s11010-008-9842-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
195 Shen Y, Liu Y, Liu S, Zhang A. Toll-like receptor 4 gene polymorphisms and susceptibility to bladder cancer. Pathol Oncol Res 2013;19:275-80. [PMID: 23065466 DOI: 10.1007/s12253-012-9579-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
196 Guo H, Chen Y, Hu X, Qian G, Ge S, Zhang J. The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells. Mol Cancer. 2013;12:77. [PMID: 23866094 DOI: 10.1186/1476-4598-12-77] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
197 Tafazzol A, Duan Y. Key residues in TLR4-MD2 tetramer formation identified by free energy simulations. PLoS Comput Biol 2019;15:e1007228. [PMID: 31609969 DOI: 10.1371/journal.pcbi.1007228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
198 Kim MJ, Min Y, Im JS, Son J, Lee JS, Lee KY. p62 is Negatively Implicated in the TRAF6-BECN1 Signaling Axis for Autophagy Activation and Cancer Progression by Toll-Like Receptor 4 (TLR4). Cells 2020;9:E1142. [PMID: 32384667 DOI: 10.3390/cells9051142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
199 Júnior LAL, Cucielo MS, Domeniconi RF, Dos Santos LD, Silveira HS, da Silva Nunes I, Martinez M, Martinez FE, Fávaro WJ, Chuffa LGA. P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study. ACS Omega 2019;4:21761-77. [PMID: 31891054 DOI: 10.1021/acsomega.9b02512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
200 Muccioli M, Sprague L, Nandigam H, Pate M, Benencia F. Toll-like receptors as novel therapeutic targets for ovarian cancer. ISRN Oncol 2012;2012:642141. [PMID: 22530148 DOI: 10.5402/2012/642141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
201 Wolska A, Lech-Marańda E, Robak T. Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett 2009;14:248-72. [PMID: 19096763 DOI: 10.2478/s11658-008-0048-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
202 Javaid N, Choi S. Toll-like Receptors from the Perspective of Cancer Treatment. Cancers (Basel) 2020;12:E297. [PMID: 32012718 DOI: 10.3390/cancers12020297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
203 Leizer AL, Alvero AB, Fu HH, Holmberg JC, Cheng YC, Silasi DA, Rutherford T, Mor G. Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells. Am J Reprod Immunol 2011;65:438-47. [PMID: 20825380 DOI: 10.1111/j.1600-0897.2010.00914.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
204 Matluk N, Rochira JA, Karaczyn A, Adams T, Verdi JM. A role for NRAGE in NF-kappaB activation through the non-canonical BMP pathway. BMC Biol 2010;8:7. [PMID: 20100315 DOI: 10.1186/1741-7007-8-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
205 Sato S, Itamochi H. Ovarian Cancer and Drug Resistance. Curr Obstet Gynecol Rep 2015;4:18-25. [DOI: 10.1007/s13669-014-0111-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Shaykhiev R, Behr J, Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS One 2008;3:e1393. [PMID: 18167552 DOI: 10.1371/journal.pone.0001393] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
207 Kaur D, Arora C, Raghava GPS. Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer. Mol Diagn Ther 2021;25:629-46. [PMID: 34155607 DOI: 10.1007/s40291-021-00539-1] [Reference Citation Analysis]
208 Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W. Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy. Gynecol Obstet (Sunnyvale). 2013;Suppl 4:3. [PMID: 24466501 DOI: 10.4172/2161-0932.s4-003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 66] [Article Influence: 3.1] [Reference Citation Analysis]
209 Ramhorst R, Fraccaroli L, Aldo P, Alvero AB, Cardenas I, Leirós CP, Mor G. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol 2012;67:17-27. [PMID: 21819477 DOI: 10.1111/j.1600-0897.2011.01056.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
210 Yoon MS, Lee YJ, Shin HJ, Park CW, Han SB, Jung JK, Kim JS, Shin DH. Recent Advances and Challenges in Controlling the Spatiotemporal Release of Combinatorial Anticancer Drugs from Nanoparticles. Pharmaceutics 2020;12:E1156. [PMID: 33261219 DOI: 10.3390/pharmaceutics12121156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]